Adia Med of Winter Park LLC Autism Spectrum Disorder Research Study

Last updated: September 17, 2026
Sponsor: Adia Med of Winter Park LLC
Overall Status: Active - Recruiting

Phase

1

Condition

Autism Spectrum Disorder (Asd)

Autism

Williams Syndrome

Treatment

Glutathione

Umbilical Cord Blood-Derived Stem Cells and Exosomes

Clinical Study ID

NCT07304440
Adia Med ASD Research Study
  • Ages 3-12
  • All Genders

Study Summary

This 12-month study tests whether AdiaVita (umbilical cord blood-derived stem cells and exosomes) plus glutathione improves autism symptoms more than glutathione alone in children ages 3-12. About 100 children with confirmed autism will be randomly assigned to one of two groups. One group receives monthly IV AdiaVita plus IV glutathione for 3 months. The other group receives IV glutathione plus a saline placebo infusion for 2 months. Both groups also use a topical glutathione spray twice a day at home. Symptoms are tracked with the Autism Treatment Evaluation Checklist (ATEC), completed by a parent and by a therapist or teacher. Safety is monitored at clinic visits through Month 12. Children who first receive glutathione only, may crossover to receive AdiaVita at no extra cost if they stay medically stable and their family agrees. Participation is voluntary. The study fee is $12,000.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 3-12 years

  • Confirmed ASD diagnosis (DSM-5 criteria, supported by ADOS-2)

  • Parent/guardian willingness to consider experimental treatments and comply withstudy requirements

  • Ability to attend all scheduled visits

  • Able to meet study cost requirements ($12,000 study fee plus bloodwork costs, ifapplicable) as described in the informed consent

Exclusion

Exclusion Criteria:

  • Severe allergies to study products

  • Significant uncontrolled medical conditions

  • Pregnancy or breastfeeding (if applicable)

  • Participation in another interventional trial within 30 days

  • Prior stem cell or glutathione therapy: History of stem cell therapy (includingumbilical cord blood-derived stem cells or exosomes) or glutathione therapy (intravenous or topical) at any time prior to screening

Study Design

Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Glutathione
Phase: 1
Study Start date:
May 01, 2026
Estimated Completion Date:
June 15, 2028

Connect with a study center

  • Adia Med Of Winter Park

    Winter Park, Florida 32789
    United States

    Active - Recruiting

  • The Lyday Center

    Green Bay, Wisconsin 54311
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.